High-throughput Parallel Sequencing to Measure Fitness of Leptospira interrogans Transposon Insertion Mutants During Golden Syrian Hamster Infection
December 18th, 2017
8.4K views
We describe here a technique that combines transposon mutagenesis with high-throughput sequencing to identify and quantify transposon leptospiral mutants in tissues after a challenge of hamsters. This protocol can be used to screen mutants for survival and dissemination in animals and can also be applied to in vitro studies.
Overview
This article presents a high-throughput transposon sequencing technique aimed at identifying and quantifying transposon mutants in Leptospira. The method is applicable for studying both in vivo and in vitro fitness defects of these mutants.
Key Study Components
Area of Science
- Microbiology
- Genetics
- Pathogenesis
Background
- Leptospira is a genus of bacteria known to cause leptospirosis.
- Understanding the virulence factors of Leptospira is crucial for developing treatments.
- Transposon mutagenesis allows for the identification of genes involved in bacterial fitness.
- This technique can be applied to various strains and infection models.
Purpose of Study
- To identify genes involved in the colonization and survival of Leptospira in hosts.
- To screen a large number of mutants with minimal animal usage.
- To enhance understanding of Leptospira virulence mechanisms.
Methods Used
- Transposon mutagenesis combined with high-throughput sequencing.
- In vivo studies using hamster models of acute leptospirosis.
- Application of the method to chronic infection models and in vitro studies.
- Screening for fitness defects in various Leptospira strains.
Main Results
- Identification of key genes associated with virulence in Leptospira.
- Demonstration of the method's efficiency in screening mutants.
- Insights into the survival and dissemination mechanisms of Leptospira.
- Potential applications in further research on leptospirosis.
Conclusions
- The high-throughput transposon sequencing technique is effective for studying Leptospira mutants.
- This method can significantly advance research in the field of Leptospira virulence.
- Future studies can leverage this technique for broader applications in microbiology.
Frequently Asked Questions
What is transposon mutagenesis?
Transposon mutagenesis is a method used to create mutations in an organism's genome by inserting transposons, which can disrupt gene function.
How does high-throughput sequencing work?
High-throughput sequencing allows for the rapid sequencing of large amounts of DNA, enabling the identification of mutations across many samples simultaneously.
What are the advantages of using hamsters in this study?
Hamsters are a suitable model for studying leptospirosis due to their susceptibility to Leptospira infection, allowing for effective in vivo analysis.
Can this method be applied to other bacterial species?
While this method is designed for Leptospira, the principles of transposon mutagenesis and high-throughput sequencing can be adapted for other bacterial species.
What are the implications of identifying virulence genes?
Identifying virulence genes can lead to the development of targeted therapies and vaccines, improving disease management and prevention.
Is this technique suitable for studying chronic infections?
Yes, the technique can be adapted for studying chronic infections, providing insights into long-term bacterial survival and host interactions.
Executive Industry Relevance
This high-throughput transposon sequencing approach enables systematic identification of virulence determinants in Leptospira interrogans by quantifying mutant fitness during hamster infection. By linking genotype to in vivo phenotype at scale, the method supports target validation and mechanistic de-risking in antimicrobial discovery programs. It reduces animal usage while increasing throughput, aligning with 3Rs principles and improving predictive confidence in early-stage target selection.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by identifying genes essential for colonization, dissemination, and survival in host tissues.
- Operational Value: Screens thousands of mutants using limited animal numbers, accelerating target identification timelines.
- Scientific Value: Provides quantitative fitness metrics that support biological de-risking and prioritization of high-confidence virulence factors.
Screening & Assay Development
- Scientific Value: Generates standardized, reproducible input and output pools for comparative fitness analysis across conditions.
- Operational Value: Produces quantitative sequencing readouts that enable precise measurement of mutant enrichment or depletion.
- Scientific Value: Supports assay scalability across infection models (acute/chronic) and in vitro systems for cross-platform validation.
Translational & Preclinical Research
- Scientific Value: Identifies genes with attenuated fitness in vivo, providing mechanistic insights into virulence pathways relevant to disease models.
- Operational Value: Enables follow-up validation of candidate targets in individual mutant studies to confirm phenotypic attenuation.
- Scientific Value: Facilitates translational continuity from discovery through preclinical validation by linking genetic lesions to phenotypic outcomes.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, supporting hypothesis-driven target identification and preclinical validation by delivering fitness-defect data that informs lead optimization and go/no-go decisions.
- Discovery Biology: Supports systematic testing of gene essentiality in virulence pathways through comparative fitness profiling.
- Screening: Delivers assay-ready mutant pools with standardized preparation and quantification for reliable compound or condition screening.
- Analytics: Generates sequencing-based readouts (output/input ratios) that enable statistical comparison of mutant abundance across conditions.
- Translational Research: Connects genetic hits to phenotypic attenuation in vivo, supporting biomarker-aligned target selection.
- Enterprise Reuse: Establishes a reusable platform for fitness screening applicable to multiple Leptospira strains and infection models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing false positives through genome-scale fitness assessment.
- Operational Value: Enhances reproducibility and standardization via barcoded library preparation and normalized input pooling.
- Strategic Value: Improves capital efficiency by enabling large-scale mutant screening with minimal animal cohorts.
- Portfolio Impact: Supports risk-adjusted advancement decisions by providing quantitative fitness data for target prioritization.
Implementation Considerations
- Requires expertise in transposon mutagenesis, PCR-based library preparation, and high-throughput sequencing data analysis.
- Depends on access to sonication equipment, fluorometry for DNA quantification, and sequencing infrastructure.
- Necessitates cross-team standardization of mutant pooling, animal challenge protocols, and tissue harvesting procedures.
- Involves adaptation considerations for different animal models (e.g., rats) and culture conditions to maintain library complexity.
- Includes practical limitations such as potential bottlenecks in mutant representation and the need for sufficient sequencing depth to detect low-abundance variants.
Biopharma FAQs
Why does null hypothesis testing matter for target validation in transposon sequencing?
Null hypothesis testing determines whether observed changes in mutant abundance between input and output pools are statistically significant, ensuring that fitness defects are not due to random variation. This supports confident target selection by distinguishing true virulence genes from background noise.
How does independent variable isolation fit the discovery pipeline in this Tn-Seq method?
Independent variable isolation is achieved by comparing mutant pools where the only variable is the presence or absence of a transposon insertion, allowing direct attribution of fitness changes to specific gene disruptions. This enables precise target validation in early discovery by linking genotype to phenotype.
What quantitative dependent variable measurements enable fitness assessment in this assay?
The dependent variable is the ratio of sequencing read counts for each mutant in the output pool (post-infection) relative to the input pool (pre-infection), quantifying in vivo fitness. These measurements enable identification of mutants with significant enrichment or depletion, indicating altered virulence potential.
Why do replication requirements matter for cross-functional collaboration in this screening approach?
Biological replicates ensure that fitness measurements are consistent across animals, reducing variability and increasing confidence in hit selection for downstream teams. This supports reliable handoff between discovery, assay development, and preclinical groups by providing robust, reproducible data.
What statistical analysis capabilities are required before implementing this transposon sequencing approach?
Implementation requires capabilities for normalizing sequencing counts, calculating log-fold changes, and applying statistical tests (e.g., negative binomial models) to identify significant fitness defects. These analyses are essential for converting raw sequencing data into actionable target validation insights.
